ACRBP and ovarian cancer: Subsequently, we found that the expression of OY‐TES‐1 protein in ovarian cancer was 81%, the positive rate of epithelial ovarian cancer was 66.4% (71/107), and the positive rate of nonepithelial ovarian cancer was 14.9% (16/107).34